Galapagos NV
GLPG
#4557
Rank
A$2.98 B
Marketcap
A$45.26
Share price
-0.42%
Change (1 day)
7.87%
Change (1 year)

P/E ratio for Galapagos NV (GLPG)

P/E ratio as of March 2026 (TTM): -95.7

According to Galapagos NV's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -95.6605. At the end of 2024 the company had a P/E ratio of 23.4.

P/E ratio history for Galapagos NV from 2015 to 2025

PE ratio at the end of each year

Year P/E ratio Change
202423.4104.48%
202311.5-191.92%
2022-12.5-59.81%
2021-31.079.18%
2020-17.3-124.16%
201971.6-150.69%
2018-141323.07%
2017-33.4-164.57%
201651.7-399.85%
2015-17.2-222.8%
201414.0-125.86%
2013-54.3-27%
2012-74.4

P/E ratio for similar companies or competitors

Company P/E ratio P/E ratio differencediff. Country
Johnson & Johnson
JNJ
22.0-122.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
29.0-130.35%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
94.8-199.13%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
21.3-122.27%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
16.1-116.78%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
36.1-137.71%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
14.5-115.14%๐Ÿ‡ฌ๐Ÿ‡ง UK
Fortress Biotech
FBIO
-5.41-94.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
23.8-124.88%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.